Cargando…

Lessons from a global antimicrobial resistance surveillance network

The World Health Organization developed the Tricycle surveillance programme to obtain a global picture of antimicrobial resistance, especially in countries with limited surveillance capacity. The programme was developed within a One Health perspective. Tricycle provides a framework for applying a st...

Descripción completa

Detalles Bibliográficos
Autor principal: Ruppé, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523813/
https://www.ncbi.nlm.nih.gov/pubmed/37772195
http://dx.doi.org/10.2471/BLT.22.289520
_version_ 1785110642942803968
author Ruppé, Etienne
author_facet Ruppé, Etienne
author_sort Ruppé, Etienne
collection PubMed
description The World Health Organization developed the Tricycle surveillance programme to obtain a global picture of antimicrobial resistance, especially in countries with limited surveillance capacity. The programme was developed within a One Health perspective. Tricycle provides a framework for applying a standardized technical protocol to determining the prevalence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in three sectors: the human, animal and environment sectors. Regular use of the protocol would enable information to be obtained on time trends and on inter- and intraregional variations, thereby generating dynamic data on antibacterial resistance for decision-makers. To date, 19 countries have begun implementing the Tricycle protocol, while other countries will start implementation in the coming years. The Network for Enhancing Tricycle ESBL Surveillance Efficiency (NETESE) was established to support countries implementing the Tricycle protocol. Currently, NETESE includes representatives from 15 institutions in eight low- or middle-income countries at different stages of Tricycle protocol implementation, and from four European countries involved in devising the protocol. This paper describes the Tricycle protocol, reports the initial experiences of NETESE participants with its implementation and discusses future challenges and opportunities.
format Online
Article
Text
id pubmed-10523813
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher World Health Organization
record_format MEDLINE/PubMed
spelling pubmed-105238132023-10-01 Lessons from a global antimicrobial resistance surveillance network Ruppé, Etienne Bull World Health Organ Policy & Practice The World Health Organization developed the Tricycle surveillance programme to obtain a global picture of antimicrobial resistance, especially in countries with limited surveillance capacity. The programme was developed within a One Health perspective. Tricycle provides a framework for applying a standardized technical protocol to determining the prevalence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in three sectors: the human, animal and environment sectors. Regular use of the protocol would enable information to be obtained on time trends and on inter- and intraregional variations, thereby generating dynamic data on antibacterial resistance for decision-makers. To date, 19 countries have begun implementing the Tricycle protocol, while other countries will start implementation in the coming years. The Network for Enhancing Tricycle ESBL Surveillance Efficiency (NETESE) was established to support countries implementing the Tricycle protocol. Currently, NETESE includes representatives from 15 institutions in eight low- or middle-income countries at different stages of Tricycle protocol implementation, and from four European countries involved in devising the protocol. This paper describes the Tricycle protocol, reports the initial experiences of NETESE participants with its implementation and discusses future challenges and opportunities. World Health Organization 2023-10-01 2023-09-06 /pmc/articles/PMC10523813/ /pubmed/37772195 http://dx.doi.org/10.2471/BLT.22.289520 Text en (c) 2023 The authors; licensee World Health Organization. https://creativecommons.org/licenses/by/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode (https://creativecommons.org/licenses/by/3.0/igo/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
spellingShingle Policy & Practice
Ruppé, Etienne
Lessons from a global antimicrobial resistance surveillance network
title Lessons from a global antimicrobial resistance surveillance network
title_full Lessons from a global antimicrobial resistance surveillance network
title_fullStr Lessons from a global antimicrobial resistance surveillance network
title_full_unstemmed Lessons from a global antimicrobial resistance surveillance network
title_short Lessons from a global antimicrobial resistance surveillance network
title_sort lessons from a global antimicrobial resistance surveillance network
topic Policy & Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523813/
https://www.ncbi.nlm.nih.gov/pubmed/37772195
http://dx.doi.org/10.2471/BLT.22.289520
work_keys_str_mv AT ruppeetienne lessonsfromaglobalantimicrobialresistancesurveillancenetwork
AT lessonsfromaglobalantimicrobialresistancesurveillancenetwork